BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

22 articles for thisTarget

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
20
Structure-Based Design of an Iminoheterocyclicß-Site Amyloid Precursor Protein Cleaving Enzyme (BACE) Inhibitor that Lowers Central Aß in Nonhuman Primates.EBI
Merck Research Laboratories
8
 
Macrolide-type motilin receptor agonists: Assessment of the biological value of the 2- and 4-hydroxyl groups of acid-stable 8,9-anhydroerythromycin A 6,9-hemiacetalsEBI
TBA
7
 
Potent, acid-stable and orally active macrolide-type motilin receptor agonists, GM-611 and the derivativesEBI
TBA
20
Identification of small molecule agonists of the motilin receptor.EBI
Glaxosmithkline
1
9-Dihydroerythromycin ethers as motilin agonists--developing structure-activity relationships for potency and safety.EBI
Kosan Biosciences
27
9-Dihydroerythromycins as non-antibiotic motilin receptor agonists.EBI
Kosan Biosciences
25
Structure-activity relationships of 9-substituted-9-dihydroerythromycin-based motilin agonists: optimizing for potency and safety.EBI
Kosan Biosciences
13
Discovery of N-(3-fluorophenyl)-1-[(4-([(3S)-3-methyl-1-piperazinyl]methyl)phenyl)acetyl]-4-piperidinamine (GSK962040), the first small molecule motilin receptor agonist clinical candidate.EBI
Glaxosmithkline
53
Discovery of a new class of macrocyclic antagonists to the human motilin receptor.EBI
Tranzyme Pharma
14
Discovery of a potent and novel motilin agonist.EBI
Bristol Myers Squibb
19
The role of the 4''-hydroxyl on motilin agonist potency in the 9-dihydroerythromycin series.EBI
Kosan Biosciences
1
Spiroindolones, a potent compound class for the treatment of malaria.EBI
Swiss Tropical and Public Health Institute
49
The discovery and optimisation of benzazepine sulfonamide and sulfones as potent agonists of the motilin receptor.EBI
Glaxosmithkline
10
Discovery of novel motilin antagonists: Conversion of tetrapeptide leads to orally available peptidomimetics.EBI
Chugai Pharmaceutical
38
The discovery of biaryl carboxamides as novel small molecule agonists of the motilin receptor.EBI
Glaxosmithkline
3
(R)-PFI-2 is a potent and selective inhibitor of SETD7 methyltransferase activity in cells.EBI
University of Toronto
3
NVP-BHG712: Effects of Regioisomers on the Affinity and Selectivity toward the EPHrin Family.EBI
Johann Wolfgang Goethe University
33
Potent macrocyclic antagonists to the motilin receptor presenting novel unnatural amino acids.EBI
Tranzyme Pharma
17
Synthesis and SAR of 1,3-disubstituted cyclohexylmethyl urea and amide derivatives as non-peptidic motilin receptor antagonists.EBI
Johnson & Johnson Pharmaceutical Research & Development
22
Discovery of DS-3801b, a non-macrolide GPR38 agonist with N-methylanilide structure.EBI
Daiichi Sankyo
11
Design and synthesis of motilin antagonists derived from the [1-4] fragment of porcine motilin.EBI
Chugai Pharmaceutical